LLY

915.4

+2.86%↑

JNJ

243.28

+0.21%↑

ABBV

216.93

+1.8%↑

NVS

151.84

+0.98%↑

MRK

120.12

+1.68%↑

LLY

915.4

+2.86%↑

JNJ

243.28

+0.21%↑

ABBV

216.93

+1.8%↑

NVS

151.84

+0.98%↑

MRK

120.12

+1.68%↑

LLY

915.4

+2.86%↑

JNJ

243.28

+0.21%↑

ABBV

216.93

+1.8%↑

NVS

151.84

+0.98%↑

MRK

120.12

+1.68%↑

LLY

915.4

+2.86%↑

JNJ

243.28

+0.21%↑

ABBV

216.93

+1.8%↑

NVS

151.84

+0.98%↑

MRK

120.12

+1.68%↑

LLY

915.4

+2.86%↑

JNJ

243.28

+0.21%↑

ABBV

216.93

+1.8%↑

NVS

151.84

+0.98%↑

MRK

120.12

+1.68%↑

Начало・Списък с акции・McKesson Corp

McKesson Corp

Отворен

СекторЗдравеопазване

859.07 -0.37

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

845.04

Максимум

864.21

Ключови измерители
By Trading Economics
Приходи	40M 1.3B
Продажби	3B 106B
P/E Средно за сектора	25.318 57.05
Дивидентна доходност	0.35
Марж на печалбата	1.177
Служители	43,000
EBITDA	374M 1.8B

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+15.24% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	0.35% 2.52%
Следващи печалби	7.05.2026 г.
Следваща дата на дивидент	1.04.2026 г.
Следваща дата на екс-дивидент	1.06.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	3B 108B
Предишно отваряне	859.44
Предишно затваряне	859.07

Настроения в новините

By Acuity

43%

57%

151 / 349 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

681.92 / 707.28 Подкрепа & съпротива

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

30.03.2026 г., 23:15 ч. UTC

Значими събития в новините

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30.03.2026 г., 22:36 ч. UTC

Значими събития в новините

Australian Government Rules Out Boots on the Ground in the Middle East

30.03.2026 г., 22:13 ч. UTC

Придобивния, сливания и поглъщания

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30.03.2026 г., 21:00 ч. UTC

Печалби

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30.03.2026 г., 20:15 ч. UTC

Значими събития в новините

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30.03.2026 г., 23:40 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

30.03.2026 г., 23:40 ч. UTC

Пазарно говорене

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30.03.2026 г., 23:36 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30.03.2026 г., 23:12 ч. UTC

Пазарно говорене

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30.03.2026 г., 22:49 ч. UTC

Пазарно говорене

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30.03.2026 г., 22:44 ч. UTC

Пазарно говорене

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30.03.2026 г., 22:43 ч. UTC

Пазарно говорене

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30.03.2026 г., 22:42 ч. UTC

Пазарно говорене

South32 Should Go for Growth, Says New Bull -- Market Talk

30.03.2026 г., 22:18 ч. UTC

Пазарно говорене

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30.03.2026 г., 22:05 ч. UTC

Пазарно говорене

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30.03.2026 г., 21:58 ч. UTC

Придобивния, сливания и поглъщания

Sun Life Financial Agrees to Buy Bell Partners for $350M

30.03.2026 г., 21:39 ч. UTC

Придобивния, сливания и поглъщания

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30.03.2026 г., 21:38 ч. UTC

Придобивния, сливания и поглъщания

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30.03.2026 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30.03.2026 г., 21:25 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

30.03.2026 г., 21:25 ч. UTC

Пазарно говорене

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30.03.2026 г., 21:03 ч. UTC

Придобивния, сливания и поглъщания

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

30.03.2026 г., 20:09 ч. UTC

Печалби

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30.03.2026 г., 20:00 ч. UTC

Значими събития в новините

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

15.24% нагоре

12-месечна прогноза

Среден 991.22 USD 15.24%

Висок 1,107 USD

Нисък 885 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

Купи

Задържане

Продай

Според 11 анализатори, дали борсови рейтинги на McKesson Corp през последните 3 месеца.

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There are no events.

Настроение

By Acuity

151 / 349 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.